-
Affymax and Takeda Announce a Nationwide Voluntary Recall of All Lots of OMONTYS® (peginesatide) Injection
26 Feb 2013 12:04 GMT
… ESAs in patients with cancer, increased risk for death … recurrence in patients with cancer receiving ESAs.In controlled … patients receiving treatment for cancer and whose anemia is … information on Affymax, please visit www.affymax.com.Affymax Forward-Looking …
-
Chemotherapy-Induced Anemia Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), | DelveInsight
22 Mar 2024 07:30 GMT
… attributed to head and neck cancers during this period. These projections … Cadila, FibroGen, Johnson & Johnson, Affymax, Chugai Pharmaceutical, Hoffmann-La Roche … -related condition among individuals with cancer is anemia. Chemotherapy-Induced Anaemia …
-
OmniAb Reports Third Quarter 2023 Financial Results and Business Highlights
09 Nov 2023 13:17 GMT
… of recurrent or metastatic cervical cancer in patients with positive PD … approved in China for cervical cancer, and the third one globally … Inc., Dialpad Inc., Mblox Inc., Affymax, Inc. and Connetics Corporation, among …
-
CARGO Therapeutics Appoints Biotech Life Sciences Leaders to Board of Directors
24 Aug 2023 13:05 GMT
… including Johnson & Johnson, Affymax, Rhone-Poulenc Rorer, Genentech and … cell therapies to patients with cancer.” Mr. Lubner serves on … T-cell therapies to outsmart cancer. Our lead clinical program, … be curative for more cancer patients. Our founders are …